Home  >  Products  >  Galnt13 (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) ) Blocking Peptide (the C terminal of Galnt13)(100ug)
Galnt13 (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) ) Blocking Peptide (the C terminal of Galnt13)(100ug)

Galnt13 (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) ) Blocking Peptide (the C terminal of Galnt13)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Galnt13 Antibody (ARP50223_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Rat
Presku: AAP50223
Size: 100ug
Weight: 61kDa
Gene: 311039
Format: Lyophilized powder
Target: Human homolog is a member of a family of proteins which catalyze the transfer of N-acetyl-alpha-d-galactosamine to polypeptides such as mucin which initiates O-Linked glycosylation.
Alternative names: T13